🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 8 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
02/12/1992 0,1193 USD
31/08/1992 0,1193 USD
02/06/1992 0,1097 USD
02/03/1992 0,1097 USD
02/12/1991 0,1002 USD
30/08/1991 0,1002 USD
03/06/1991 0,0891 USD
04/03/1991 0,0891 USD
03/12/1990 0,0891 USD
28/08/1990 0,0891 USD
29/05/1990 0,0716 USD
05/03/1990 0,0716 USD
04/12/1989 0,0716 USD
29/08/1989 0,0716 USD
30/05/1989 0,0652 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/03/1997 43,54 43,65 42,04 42,88 -1,37% 3,70% 7.326.358
21/03/1997 43,42 44,19 42,94 43,48 +0,41% 2,88% 8.786.642
20/03/1997 43,59 43,71 43,06 43,30 -0,82% 1,50% 5.254.253
19/03/1997 43,18 43,83 42,64 43,65 +1,24% 2,76% 6.582.069
18/03/1997 43,83 43,89 42,88 43,12 -0,82% 2,31% 5.616.651
17/03/1997 42,22 43,54 42,16 43,48 +3,11% 3,25% 9.014.896
14/03/1997 43,18 43,30 41,63 42,16 -2,35% 3,87% 10.417.120
13/03/1997 43,54 44,01 43,06 43,18 -1,90% 2,19% 5.238.952
12/03/1997 44,43 44,61 43,65 44,01 -1,73% 2,15% 3.958.925
11/03/1997 45,50 45,50 44,67 44,79 -1,57% 1,83% 3.976.112
10/03/1997 44,79 45,56 44,61 45,50 +2,55% 2,13% 5.720.403
07/03/1997 44,01 44,91 43,71 44,37 +0,81% 2,71% 7.589.197
06/03/1997 44,85 44,85 43,89 44,01 -1,86% 2,13% 5.380.432
05/03/1997 43,65 44,91 43,54 44,85 +3,01% 3,14% 6.519.189
04/03/1997 44,85 44,91 43,00 43,54 -2,93% 4,26% 6.082.382
03/03/1997 43,24 44,91 43,24 44,85 +2,04% 3,86% 5.721.242
28/02/1997 44,01 44,49 43,42 43,95 -1,86% 2,44% 8.489.219
27/02/1997 46,34 46,46 44,61 44,79 -3,59% 3,99% 5.881.795
26/02/1997 46,22 46,70 45,09 46,46 -0,38% 3,48% 7.383.579
25/02/1997 46,93 46,93 45,80 46,64 -0,64% 2,41% 6.810.533
24/02/1997 45,15 47,05 45,15 46,93 +3,42% 4,23% 5.534.488
21/02/1997 46,10 46,22 45,15 45,38 -1,42% 2,33% 8.116.970
20/02/1997 46,76 46,93 45,86 46,04 -1,53% 2,30% 6.116.128
19/02/1997 47,11 47,53 46,40 46,76 -1,26% 2,41% 5.229.939
18/02/1997 46,46 47,59 46,40 47,35 +1,93% 2,57% 7.383.370
14/02/1997 46,99 47,35 46,34 46,46 -2,26% 2,16% 8.403.074
13/02/1997 45,80 47,65 45,80 47,53 +3,91% 4,04% 8.343.338
12/02/1997 44,37 45,74 44,31 45,74 +3,09% 3,23% 7.465.323
11/02/1997 44,19 44,37 43,65 44,37 +0,68% 1,62% 4.075.882
10/02/1997 44,61 44,73 44,01 44,07 -1,20% 1,60% 4.239.998